Viking Therapeutics (VKTX) Non-Current Assets (2014 - 2026)

Viking Therapeutics has disclosed Non-Current Assets across 13 years of filings, most recently posting $33000.0 for Q1 2026.

• Non-Current Assets for Q1 2026 came in at $33000.0, down 96.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (down 61.39% YoY), and the FY2025 annual result was $131000.0, down 88.14% from the prior year.
• Non-Current Assets came in at $33000.0 for Q1 2026 at Viking Therapeutics, down from $131000.0 in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $1.7 million in Q1 2022 to a low of $33000.0 in Q1 2026.
• The 5-year median for Non-Current Assets is $1.2 million (2024), against an average of $1.1 million.
• Across the five-year window, Non-Current Assets jumped 1011.19% in 2022 and tumbled 96.6% in 2026, its largest moves.
• Viking Therapeutics' Non-Current Assets stood at $1.5 million in 2022, then decreased by 15.04% to $1.3 million in 2023, then slipped by 12.65% to $1.1 million in 2024, then plunged by 88.14% to $131000.0 in 2025, then tumbled by 74.81% to $33000.0 in 2026.
• The last three Non-Current Assets figures came in at $33000.0 (Q1 2026), $131000.0 (Q4 2025), and $712000.0 (Q3 2025), per Business Quant data.